Aromatase is the enzyme responsible for converting androgens into estrogens, and in men it turns out to be far more important than most people realize. Encoded by the CYP19A1 gene, this enzyme operates in the testes, brain, fat tissue, bone, and other organs, quietly producing the estrogen that men need for healthy bones, functioning blood vessels, normal fertility, and even brain protection after injury.1PubMed. Aromatase: Contributions to Physiology and Disease in Women and Men When aromatase activity is too low or too high, the consequences range from brittle bones and metabolic syndrome to infertility and enlarged breast tissue.
How the Enzyme Works
Aromatase belongs to the cytochrome P450 family of enzymes. Its specific job is to strip a carbon from the 19-carbon androgen molecule and reshape the remaining structure into an 18-carbon estrogen. In practical terms, it converts testosterone into estradiol and androstenedione into estrone.2Medicina ClÃnica Práctica. Aromatase inhibitors in male: A literature review This reaction happens not just in the gonads but across a surprisingly broad range of tissues. The testes are a major site, but aromatase is also active in fat cells, brain tissue, bone cells, and the prostate.3PubMed Central. Tissue physiology and pathology of aromatase That wide distribution signals something important: the estrogen made locally in each tissue does specific work there, rather than simply contributing to a general circulating pool. In fat tissue, for instance, aromatase expression patterns differ by fat depot and even by sex, with one mouse study showing that aromatase was expressed in the male gonadal fat pad but not in the same tissue in females.4PubMed Central. A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue
Why Men Need Estrogen for Strong Bones
If you think of estrogen as strictly a female hormone, the skeleton is where that assumption falls apart fastest. Most of the key events in male bone development and maintenance are now considered to be under the control of estrogen. During puberty, locally produced estradiol accelerates bone growth and then triggers the closure of growth plates, which is what stops you from getting taller. During adulthood, a critical threshold of circulating estradiol appears to be necessary for maintaining bone density, because estrogen modulates both the building-up and breaking-down of bone tissue.5PubMed Central. The endocrine role of estrogens on human male skeleton
The bone evidence becomes especially vivid when aromatase is deliberately suppressed. In a trial of older men with low testosterone, those given the aromatase inhibitor anastrozole saw their spinal bone mineral density decrease over the study period, while men on placebo saw a slight increase. The researchers concluded that aromatase inhibition does not improve skeletal health in aging men and may actively harm it.6PubMed Central. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels This finding matters for clinical practice: raising testosterone by blocking its conversion to estradiol can backfire if the real problem for bones was insufficient estrogen all along.
Aromatase in the Brain
The brain is one of the most active sites of aromatase expression, and the estrogen produced there serves two broad purposes. First, it is part of testosterone’s signaling pathway in the brain. Many of the effects traditionally attributed to testosterone in organizing and activating male-typical neural circuits actually depend on testosterone being converted to estradiol locally. Research in non-human primates and sheep has shown that brain aromatase influences androgen feedback sensitivity and even sexual partner preferences.7PubMed Central. Brain aromatase: roles in reproduction and neuroprotection
Second, brain aromatase appears to be protective after injury. When the brain is damaged, aromatase expression ramps up in a type of support cell called astrocytes. The resulting local surge in estrogen interferes with the cell-death pathways that cause secondary damage after a stroke or traumatic injury, slowing degeneration and potentially even supporting the generation of new cells. The net effect is that aromatization in the brain reduces the overall extent of damage.8PubMed Central. Neuroprotective actions of brain aromatase This neuroprotective role is still being mapped out, but it adds yet another reason that systemically shutting down aromatase activity could carry unintended costs.
Blood Vessel Health
Estrogen’s protective reputation in cardiovascular health usually centers on premenopausal women. But the same protective effect shows up in men. In healthy young men, suppressing estrogen production with anastrozole led to a significant drop in flow-mediated dilation, a standard measure of how well blood vessels relax in response to blood flow. The median dropped from about 6% to about 3.5%, without any accompanying changes in cholesterol or inflammatory markers. The researchers concluded that endogenous estrogens play a direct role in maintaining endothelial function in men.9PubMed. Endogenous estrogens influence endothelial function in young men
Observational data in middle-aged men points in the same direction. Higher estradiol levels correlate with better flow-mediated dilation, and that association holds even after accounting for body weight and cholesterol levels.10PubMed. Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels This is a piece of evidence that often gets lost in the conversation around testosterone therapy: the estradiol that aromatase produces from testosterone is not a wasteful byproduct. It is actively keeping blood vessels flexible.
Spermatogenesis and Male Fertility
The relationship between aromatase and sperm production is a delicate balance. The testes produce considerable amounts of estrogen through aromatase, and estrogen receptors are present throughout the testicular cells involved in making sperm. The current understanding is that spermatogenesis is partly governed by the ratio of androgens to estrogens, with aromatase acting as the dial between them.11PubMed Central. Oestrogens and spermatogenesis
What happens when aromatase is missing entirely? Studies in mice with a knocked-out aromatase gene are striking. The males start out fertile but develop progressive infertility over time. By about one year of age, sperm production is severely disrupted, with arrest at early stages, increased cell death, and a dramatic drop in the number of mature sperm cells, even though testosterone and gonadotropin levels remain normal. This demonstrated that local estrogen production in the testes is essential for sustained sperm development.12PubMed. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene
The Obesity-Aromatase Cycle
Fat tissue is a major site of aromatase activity, and this creates a feedback loop that helps explain why obese men often develop hormonal imbalances. In men with obesity, aromatase gene expression in fat cells increases in step with body mass index, waist-hip ratio, body fat percentage, and markers of insulin resistance.13PubMed Central. Altered Expression of Aromatase and Estrogen Recipients in Adipose Tissue From Men With Obesity or Type 2 Diabetes Visceral fat, in particular, is strongly correlated with higher estradiol levels and a lower testosterone-to-estradiol ratio, while subcutaneous fat shows a weaker relationship.14PubMed. Associations between visceral adipose tissue, inflammation and sex steroid concentrations in men
The mechanism connecting fat gain to increased aromatase involves inflammation. Obesity triggers a chronic, low-grade inflammatory state in fat tissue. The resulting surge in pro-inflammatory signaling molecules ramps up transcription of the CYP19 gene, leading to more aromatase protein in those fat cells, which in turn converts more testosterone to estradiol.15PubMed Central. Research Progress on the Relationship between Obesity-Inflammation-Aromatase Axis and Male Infertility The extra estrogen then promotes further fat storage, perpetuating the cycle. This is why excess aromatase activity is closely linked to gynecomastia (male breast tissue enlargement) in obese men: the local estrogen-to-androgen ratio at the breast tips toward estrogen, and tissue growth follows.16PubMed. Aromatase and gynecomastia The same estrogen imbalance can contribute to gynecomastia during puberty, aging, liver disease, and thyroid overactivity.
What Happens When Aromatase Is Absent From Birth
Congenital aromatase deficiency is extremely rare, but the men who have it provide a living illustration of how much the male body depends on estrogen. At presentation, every reported case shows the same constellation: unusually tall stature, delayed bone maturation, weak or brittle bones, and eunuchoid skeletal proportions (arms and legs disproportionately long relative to the trunk).17Nature Reviews Endocrinology. Aromatase deficiency in men: a clinical perspective Their growth plates never receive the estrogen signal to close, so the bones keep growing well into adulthood.
One case report illustrates the pattern vividly: a 31-year-old man presented after gaining 5 centimeters of height over six years, along with leg cramps and bone pain. He stood 193 cm tall, had undetectable estrogen despite elevated testosterone, and imaging showed his growth plates were still open. Bone density scans revealed scores well below normal. Genetic testing confirmed a homozygous deletion in the CYP19A1 gene.18PubMed. Aromatase enzyme deficiency in an adult male patient and the effects of estrogen replacement therapy: a rare cause of tall stature In these men, estrogen replacement can halt further height gain and improve bone density, reinforcing that estrogen, not testosterone alone, is what controls bone maturation. Interestingly, tall stature may persist even when other growth signals like growth hormone are deficient, simply because the bones have so much extra time to elongate.19PubMed. Tall stature without growth hormone: four male patients with aromatase deficiency
Metabolic Fallout of Estrogen Deficiency
Beyond bones, the absence of aromatase-derived estrogen causes metabolic disruption. Men with CYP19A1 mutations show impaired glucose and lipid metabolism, along with insulin resistance and fatty liver (hepatic steatosis). Animal studies fill in the mechanism: male mice lacking aromatase develop increased fat stores, glucose intolerance, and insulin resistance driven largely by the liver overproducing glucose. They also develop disordered lipid metabolism and fatty liver, problems that do not appear to the same degree in female mice lacking the same enzyme.20Frontiers in Endocrinology. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling This sex-specific vulnerability suggests that men depend on aromatase-derived estrogen for metabolic protection in ways that female physiology can partly compensate for through ovarian estrogen production.
Aromatase and Aging
Testosterone declines gradually as men age, but estradiol levels do not fall in lockstep. The reason is that aromatase activity tends to increase with age, partly because aging men accumulate more body fat, and fat cells are aromatase factories. The net result is that while total and free testosterone drop, circulating estradiol remains relatively stable, and the ratio of free testosterone to free estradiol shifts steadily toward estrogen.21PubMed. Estradiol in elderly men This shift is one of the mechanisms behind the increased incidence of gynecomastia and body composition changes in older men. It also means that an older man’s testosterone level alone does not tell the full hormonal story; the ratio of testosterone to estradiol may matter just as much.
Aromatase Inhibitors as Treatment
Because aromatase sits at the intersection of testosterone and estrogen, drugs that block it have attracted interest for a variety of male health conditions. Aromatase inhibitors come in two flavors: nonsteroidal drugs like anastrozole and letrozole, which bind to the enzyme reversibly, and steroidal drugs like exemestane, which bind permanently and may also have mild androgenic effects of their own.22PubMed. Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
In obese or aging men with low testosterone, aromatase inhibitors can meaningfully raise testosterone levels. A meta-analysis of clinical trials found that these drugs improved total testosterone by roughly 5 to 7 nmol/L over periods ranging from three months to a year.23PubMed Central. Role of Aromatase Inhibitors in Managing Hypogonadism in Adult Males Related to Obesity and Aging: A Systematic Review and Meta-Analysis The appeal is obvious: unlike testosterone replacement, which shuts down the body’s own production and suppresses sperm output, aromatase inhibitors leave the hypothalamic-pituitary-testicular axis intact. This makes them a tempting option for men who want to preserve fertility.
In infertile men with a low testosterone-to-estradiol ratio, aromatase inhibitors have improved both hormone profiles and semen quality.24Fertility and Sterility. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios A meta-analysis of trials in male infertility found that treated men roughly doubled their average sperm concentration, though the drugs did nothing for men who started with zero sperm in the ejaculate.25PubMed Central. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility
The tradeoffs, however, are real. As the bone and cardiovascular data show, suppressing estrogen carries skeletal and vascular costs. Combining aromatase inhibition with weight loss may mitigate some of these concerns. In one study of obese hypogonadal men, aromatase inhibitors plus dietary weight loss improved hormonal profiles without major side effects, and no participants dropped out due to the drug itself.26Frontiers in Endocrinology. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects But the long-term safety profile in men remains uncertain, and routine use is not yet recommended outside of specific clinical scenarios.27PubMed Central. Aromatase inhibitors in men: effects and therapeutic options
Growth Augmentation in Boys
Because estrogen is what closes growth plates, blocking its production can extend the window for height gain. This idea has been tested in boys with idiopathic short stature. In a randomized trial, boys treated with the aromatase inhibitor letrozole gained a predicted adult height increase of about 6 cm compared with no change in the placebo group.28The Journal of Clinical Endocrinology & Metabolism. Inhibition of Estrogen Biosynthesis with a Potent Aromatase Inhibitor Increases Predicted Adult Height in Boys with Idiopathic Short Stature: A Randomized Controlled Trial A broader network meta-analysis confirmed that letrozole was associated with the greatest height gains among several treatment strategies, including growth hormone alone.29PubMed. Comparative effects of growth hormone, testosterone, and aromatase inhibitors on height gain in children and adolescents with idiopathic short statures: a network meta-analysis
The enthusiasm needs tempering, though. A three-year randomized trial comparing anastrozole and letrozole in pubertal boys found that the predicted height gains seen at year one did not hold up at years two and three. The combined gain over three years was a modest 1.3 cm, leading the researchers to conclude that aromatase inhibitor monotherapy for height augmentation “may be limited, and safety remains an issue.”30PubMed Central. Anastrozole vs Letrozole to Augment Height in Pubertal Males With Idiopathic Short Stature: A 3-Year Randomized Trial The worry is not just about efficacy fading; delaying growth plate closure in a growing boy means altering the hormonal environment of a developing skeleton and brain during a sensitive period, and we do not yet have long-term data on what that means decades later.
Aromatase in the Prostate
The prostate expresses aromatase in its stromal cells, producing estrogen locally within the gland. This local production appears to increase in disease states. In benign prostatic hyperplasia (BPH), marked aromatase activity has been found in the proliferative cells surrounding the glands, and similar activity appears in the stromal tissue surrounding cancerous glands in prostate cancer specimens.31PubMed. Aromatase in hyperplasia and carcinoma of the human prostate In healthy prostate tissue, aromatase is confined to the stromal compartment. In malignancy, however, expression shifts into the epithelial cells and involves different gene promoters, which may alter the local testosterone-to-estrogen ratio in ways that promote disease progression.32The Journal of Steroid Biochemistry and Molecular Biology. Aromatase and regulating the estrogen:androgen ratio in the prostate gland Whether this makes aromatase a useful therapeutic target in prostate disease remains an open question, but the consistent finding of altered expression in diseased tissue keeps attracting research attention.
An Ancient Enzyme System
Aromatase is not a recent evolutionary invention. Both the enzyme and its partner protein, the reductase it needs to function, are highly conserved across mammals and vertebrates. In species as distant as fish, birds, reptiles, and amphibians, the aromatase-estrogen system plays roles in gonadal sex differentiation and testicular function, though the specific details vary by species and even between species within the same class.33PubMed Central. The Aromatase-Estrogen System in the Testes of Non-Mammalian Vertebrates Analysis of the evolutionary relationship between aromatase and the androgen receptor found highly significant parallel evolution between the two proteins across the animal kingdom, driven by their shared ligand, androgen. Proteins resembling vertebrate aromatase and androgen receptors have even been identified in sea anemones, suggesting that the endocrine machinery linking androgens and estrogens originated very early in animal evolution.34Molecular Biology and Evolution. Parallel Evolution between Aromatase and Androgen Receptor in the Animal Kingdom That level of conservation across hundreds of millions of years underscores how fundamental the androgen-to-estrogen conversion is. It is not a quirk of mammalian biochemistry; it is a core piece of the toolkit that animals have used to regulate reproduction, development, and tissue health since before vertebrates existed.